Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo (Q39671100)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 October 2010
edit
Language Label Description Also known as
English
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
scientific article published on 15 October 2010

    Statements

    Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo (English)
    15 October 2010
    788-795

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit